search
Pfizer
Trends
- 1AI Speeds Up Matching Patients to Clinical Trials●How AI Is Helping Match Patients to Clinical Trials Faster
Pfizer is highlighting how artificial intelligence is being used to match patients to clinical trials more quickly. The company says AI tools can sift through patient data and trial eligibility criteria far faster than manual screening, potentially shortening recruitment timelines and widening access to experimental treatments for patients who might otherwise be missed.
- 2Former Pfizer Executive Bill Sessa Named Chair of Isomab Advisory Board▼Professor Bill Sessa, Former Chief Scientific Officer of Internal Medicine at Pfizer, Appointed Chair of Isomab's Scientific Advisory Board
Professor Bill Sessa, formerly Chief Scientific Officer of Internal Medicine at Pfizer, has been appointed Chair of Isomab's Scientific Advisory Board. The move gives the biotech company a senior figure with decades of large-pharma experience as it advances its scientific programmes, and the announcement was distributed via PR Newswire.